Profit

Sun-Taro issue nears end

PUBLISHED ON: January 5, 2009 | Duration: 1 min, 47 sec

  
loading..
The saga of Sun Pharma's protracted battle to acquire control of Israel's Taro Pharma seems to be approaching its final hours. Sun, in a last ditch attempt at an early resolution has proposed two options. The first involves a 22 per cent premium to its earlier offer, which will cost Sun $45 million or more.
ALSO WATCH
Nifty Hits 11,600, Sensex Opens Above 38,400 For First Time

................................ Advertisement ................................

................................ Advertisement ................................